Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting

Jan Zaloga,Marina Pöttler,Gerd Leitinger,Ralf P Friedrich,Gunter Almer,Stefan Lyer,Eva Baum,Rainer Tietze,Ralph Heimke-Brinck,Harald Mangge,Frank Dörje,Geoffrey Lee,Christoph Alexiou
DOI: https://doi.org/10.1016/j.ejpb.2016.01.017
Abstract:In this work we present a new formulation of superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic drug targeting. The particles were reproducibly synthesized from current good manufacturing practice (cGMP) - grade substances. They were surface coated using fatty acids as anchoring molecules for human serum albumin. We comprehensively characterized the physicochemical core-shell structure of the particles using sophisticated methods. We investigated biocompatibility and cellular uptake of the particles using an established flow cytometric method in combination with microwave-plasma assisted atomic emission spectroscopy (MP-AES). The cytotoxic drug mitoxantrone was adsorbed on the protein shell and we showed that even in complex media it is slowly released with a close to zero order kinetics. We also describe an in vitro proof-of-concept assay in which we clearly showed that local enrichment of this SPION-drug conjugate with a magnet allows site-specific therapeutic effects.
What problem does this paper attempt to address?